From Biochemistry to Bioassays: Practical Approaches and Case Studies in ADC Testing
1 Dec, 2026 | 03:00 PM CET
Antibody-Drug Conjugates (ADCs) are among the fastest-growing and most complex therapeutic modalities in modern biopharmaceutical development. Their hybrid nature, combining a monoclonal antibody with a highly potent payload, creates unique analytical and biological testing challenges throughout development and release.
Join Eurofins BPT experts for an insightful webinar exploring practical approaches to ADC testing, from advanced biochemical characterization to potency assessment through cell-based and ligand-binding assays. Through real-world examples and a practical case study, we will demonstrate how integrated analytical and bioassay strategies can support successful ADC development, characterisation and release testing.
Speakers:
Lydia Slattery - Business Unit Manager Biopharma Biologics Dungarvan Ireland; Biologics FTE Services Ireland, Eurofins BioPharma Product Testing Ireland
Giulia Mancini - Team Cluster Manager - Bioassay & Cell & Gene Therapy, Eurofins BioPharma Product Testing Italy
Agenda:
- ADC Biochemistry: Navigating Analytical Complexity
- Why ADCs present unique analytical challenges
- Combining large- and small-molecule analytical expertise
- Potency testing complexity in ADC
- Cell-Based assay and ligan based assays in ADC
- Practical Case Study
- Q&A
Why Attend?
- The key analytical challenges associated with ADC development and testing.
- How to combine large-molecule and small-molecule expertise within a single testing strategy.
- Critical considerations for ADC potency assessment.
- Operational Flow Optimisation
- The role of cell-based and ligand-binding assays in evaluating biological activity.
- Practical solutions and lessons learned from real ADC projects.
- Regulatory-ready approaches from method establishment to release testing.
Who Should Attend?
- Analytical Development Scientists
- Bioassay Scientists
- Head of Operations / Laboratory Process
- CMC and Technical Development Teams
- Quality Control and Quality Assurance Professionals
- Manufacturing and Process Development Scientists
- Regulatory Affairs Professionals
- Project Managers overseeing ADC programs
- Pharmaceutical and Biotechnology Companies developing ADCs and other complex biologics
Whether you are developing your first ADC candidate or looking to optimise existing analytical and potency testing strategies, this webinar will provide practical insights to support your program from early development through commercialisation.
📅 1 Dec 2026 | 03:00 PM CET